Edition:
United Kingdom

People: Lannett Company Inc (LCI.N)

LCI.N on New York Stock Exchange

5.80USD
21 Jun 2019
Change (% chg)

$0.10 (+1.75%)
Prev Close
$5.70
Open
$5.65
Day's High
$5.90
Day's Low
$5.48
Volume
243,564
Avg. Vol
286,117
52-wk High
$14.65
52-wk Low
$3.34

LePore, Patrick 

Mr. Patrick G. LePore is an Independent Chairman of the Board of the Company effective July 1, 2018, He has served as chairman, CEO and president of Par Pharmaceuticals, Inc., until the company's acquisition by private equity investor TPG in 2012. He remained as chairman of the new company where he led the sale of the company to Endo Pharmaceuticals. LePore began his career with Hoffmann LaRoche. Later, he founded Boron LePore and Associates, a medical communications company, which he took public and was eventually sold to Cardinal Health. He is a member of the board of directors of PharMerica and Innoviva, and is a trustee of Villanova University. LePore earned his bachelor's degree from Villanova University and Master of Business Administration from Fairleigh Dickinson University.

Basic Compensation

Total Annual Compensation, USD 94,000
Restricted Stock Award, USD 35,785
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 129,785

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Patrick LePore

129,785

Timothy Crew

1,329,780

Martin Galvan

763,745

John Abt

565,013

Maureen Cavanaugh

--

Grant Brock

--
As Of  30 Jun 2018